Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Arthritis, Psoriatic | 7 | 2021 | 625 | 1.21 | Why? |
| Spondylarthritis | 2 | 2018 | 174 | 1.15 | Why? |
| Arthritis, Reactive | 2 | 2018 | 64 | 0.80 | Why? |
| Microbiota | 3 | 2018 | 1240 | 0.76 | Why? |
| Psoriasis | 7 | 2021 | 1739 | 0.72 | Why? |
| Gastrointestinal Microbiome | 4 | 2018 | 1961 | 0.68 | Why? |
| Joints | 1 | 2018 | 97 | 0.68 | Why? |
| Rheumatology | 4 | 2021 | 1213 | 0.64 | Why? |
| Mucous Membrane | 2 | 2018 | 305 | 0.63 | Why? |
| Autoimmune Diseases | 3 | 2020 | 1996 | 0.59 | Why? |
| Antirheumatic Agents | 3 | 2021 | 3023 | 0.47 | Why? |
| Arthritis, Rheumatoid | 3 | 2020 | 2043 | 0.42 | Why? |
| Inflammation | 5 | 2020 | 13255 | 0.40 | Why? |
| Rheumatic Diseases | 1 | 2021 | 2675 | 0.29 | Why? |
| Feeding Behavior | 1 | 2018 | 1909 | 0.29 | Why? |
| Th17 Cells | 3 | 2018 | 657 | 0.27 | Why? |
| Inflammatory Bowel Diseases | 2 | 2020 | 3209 | 0.27 | Why? |
| RNA, Ribosomal, 16S | 3 | 2018 | 793 | 0.20 | Why? |
| Lupus Erythematosus, Systemic | 2 | 2021 | 1380 | 0.20 | Why? |
| Organizations, Nonprofit | 1 | 2020 | 87 | 0.20 | Why? |
| Enthesopathy | 1 | 2018 | 21 | 0.18 | Why? |
| Synovitis | 1 | 2018 | 47 | 0.18 | Why? |
| Prebiotics | 1 | 2018 | 53 | 0.18 | Why? |
| Arthritis, Experimental | 1 | 2017 | 44 | 0.17 | Why? |
| Spondylitis, Ankylosing | 1 | 2020 | 231 | 0.17 | Why? |
| Biological Products | 3 | 2021 | 2331 | 0.17 | Why? |
| Hereditary Autoinflammatory Diseases | 1 | 2017 | 72 | 0.16 | Why? |
| HLA-A Antigens | 1 | 2018 | 196 | 0.15 | Why? |
| Janus Kinase Inhibitors | 1 | 2020 | 682 | 0.14 | Why? |
| Toll-Like Receptor 4 | 1 | 2017 | 390 | 0.13 | Why? |
| Arthritis | 1 | 2017 | 288 | 0.13 | Why? |
| Fecal Microbiota Transplantation | 1 | 2018 | 372 | 0.12 | Why? |
| Immunosuppressive Agents | 2 | 2021 | 6331 | 0.12 | Why? |
| Interleukin-17 | 1 | 2017 | 602 | 0.12 | Why? |
| New York | 1 | 2020 | 2488 | 0.12 | Why? |
| Cell Differentiation | 1 | 2018 | 1338 | 0.11 | Why? |
| Immunomodulation | 1 | 2020 | 1472 | 0.11 | Why? |
| Probiotics | 1 | 2018 | 694 | 0.10 | Why? |
| Interleukin 1 Receptor Antagonist Protein | 1 | 2017 | 1165 | 0.09 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.08 | Why? |
| Dermatology | 2 | 2020 | 1999 | 0.07 | Why? |
| Ambulatory Care Facilities | 1 | 2017 | 2063 | 0.07 | Why? |
| Disease Models, Animal | 3 | 2018 | 10998 | 0.07 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.07 | Why? |
| Immunocompromised Host | 1 | 2021 | 5150 | 0.07 | Why? |
| Feces | 1 | 2018 | 4235 | 0.07 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Humans | 17 | 2021 | 930598 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Enzyme-Linked Immunospot Assay | 1 | 2021 | 325 | 0.05 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.05 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.05 | Why? |
| Bacteroidetes | 1 | 2017 | 36 | 0.05 | Why? |
| Proteobacteria | 1 | 2017 | 36 | 0.05 | Why? |
| Helicobacter | 1 | 2017 | 7 | 0.04 | Why? |
| Ruminococcus | 1 | 2017 | 20 | 0.04 | Why? |
| Prevotella | 1 | 2017 | 18 | 0.04 | Why? |
| Firmicutes | 1 | 2017 | 41 | 0.04 | Why? |
| HLA-B27 Antigen | 1 | 2017 | 48 | 0.04 | Why? |
| Epidemiology | 1 | 2020 | 216 | 0.04 | Why? |
| Symptom Flare Up | 1 | 2021 | 432 | 0.04 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.04 | Why? |
| Infectious Disease Medicine | 1 | 2020 | 311 | 0.04 | Why? |
| Prednisone | 1 | 2021 | 652 | 0.04 | Why? |
| Adult | 6 | 2021 | 244371 | 0.04 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.04 | Why? |
| Serum Amyloid A Protein | 1 | 2017 | 211 | 0.04 | Why? |
| Animals | 4 | 2018 | 78931 | 0.04 | Why? |
| Delphi Technique | 1 | 2020 | 1257 | 0.04 | Why? |
| Glucocorticoids | 2 | 2021 | 4431 | 0.04 | Why? |
| Female | 7 | 2021 | 380317 | 0.04 | Why? |
| Male | 6 | 2021 | 367725 | 0.03 | Why? |
| Mice | 3 | 2018 | 21357 | 0.03 | Why? |
| Advisory Committees | 1 | 2020 | 1418 | 0.03 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.03 | Why? |
| Interferon-gamma | 1 | 2021 | 2711 | 0.03 | Why? |
| Th1 Cells | 1 | 2017 | 1228 | 0.03 | Why? |
| Congresses as Topic | 1 | 2021 | 1347 | 0.03 | Why? |
| Adolescent | 2 | 2018 | 86841 | 0.03 | Why? |
| Intestinal Mucosa | 1 | 2017 | 1046 | 0.02 | Why? |
| United States | 3 | 2021 | 46150 | 0.02 | Why? |
| Neutralization Tests | 1 | 2021 | 6698 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2021 | 3228 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2021 | 4418 | 0.02 | Why? |
| Aged | 2 | 2020 | 215776 | 0.02 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.02 | Why? |
| Consensus | 1 | 2020 | 6345 | 0.02 | Why? |
| Prospective Studies | 2 | 2020 | 43301 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 3633 | 0.02 | Why? |
| Immunologic Factors | 1 | 2021 | 4206 | 0.02 | Why? |
| Symptom Assessment | 1 | 2017 | 4967 | 0.02 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2019 | 48226 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2019 | 53120 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.01 | Why? |
Scher's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(105)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(98)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_